Home › Funds › Osprey Private Wealth LLC › REGN

Osprey Private Wealth LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Osprey Private Wealth LLC reported holding 9,890 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$7.5M, representing 1.81% of its reported portfolio and ranking #20 among its reported holdings. Osprey Private Wealth LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)9.89K sh
Reported value held$7.50M
Portfolio Weight1.81%
First reportedQ1 2025
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Osprey Private Wealth LLC's REGN position evolved

Osprey Private Wealth LLC first disclosed a stake in REGN in Q1 2025 at 3,530 shares (US$2.2M). The position peaked in Q3 2026 at 9,890 shares, worth US$7.5M. Across 7 filings, Osprey Private Wealth LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 9,890 shares valued at US$7.5M — an increase of 723 shares quarter over quarter.. Notable position changes include a 55% increase in Q4 2025 (shares were roughly flat over the following quarter), a 87% increase in Q1 2026 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 3.53K $2.24M New
Q2 2025 3.10K $1.70M Reduce
Q3 2025 3.24K $1.82M Add
Q4 2025 5.04K $3.89M Add
Q1 2026 9.44K $7.29M Add
Q2 2026 9.17K $5.72M Reduce
Q3 2026 9.89K $7.50M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Nuveen, LLC (US$1.48B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Osprey Private Wealth LLC held REGN?

Osprey Private Wealth LLC has disclosed REGN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Osprey Private Wealth LLC's current position in REGN?

As of Q3 2026, Osprey Private Wealth LLC holds 9.89K shares of REGN (REGENERON PHARMACEUTICALS), valued at $7.50M, representing 1.81% of its reported portfolio and ranking #20.

Has Osprey Private Wealth LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Osprey Private Wealth LLC increased its position in REGN. The position peaked in Q3 2026 at 9.89K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Nuveen, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.